News
Castle Biosciences, Inc. ( NASDAQ: CSTL) Q1 2025 Earnings Conference Call May 5, 2025 4:30 PM ET Camilla Zuckero - Vice President of Investor Relations and Corporate Affairs Derek Maetzold - Founder, ...
FRIENDSWOOD, Texas, May 05, 2025 (GLOBE NEWSWIRE) -- Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced its financial ...
Q1 2025 revenue increased 21% over Q1 2024 to $88 million Q1 2025 total test reports for our core revenue drivers (DecisionDx®-Melanoma, DecisionDx®-SCC, TissueCypher®) increased 33% over Q1 2024 Rais ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback